CYTORI THERAPEUTICS INC - COM (CYTX)

CUSIP: 23283K105

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class
Equity / COM
Total 13F shares
15,012,095
Share change
+1,300,845
Total reported value
$40,346,175
Put/Call ratio
1382%
Price per share
$2.70
Number of holders
66
Value change
+$3,568,732
Number of buys
33
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 23283K105?
CUSIP 23283K105 identifies CYTX - CYTORI THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYTORI THERAPEUTICS INC - COM (CYTX) as of Q1 2014

As of 31 Mar 2014, CYTORI THERAPEUTICS INC - COM (CYTX) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,012,095 shares. The largest 10 holders included BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, NORTHERN TRUST CORP, MARATHON CAPITAL MANAGEMENT, PERKINS CAPITAL MANAGEMENT INC, TFS CAPITAL LLC, PRINCETON CAPITAL MANAGEMENT INC, and GOLDMAN CAPITAL MANAGEMENT INC. This page lists 66 institutional shareholders reporting positions in this security for the Q1 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.